Mon, September 11, 2017
Fri, September 8, 2017
Thu, September 7, 2017
Wed, September 6, 2017
Tue, September 5, 2017

Geoff Meacham Initiated (ALNY) at Buy with Increased Target to $105 on, Sep 7th, 2017

Geoff Meacham of Barclays, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $80 to $105 on, Sep 7th, 2017.

Geoff has made no other calls on ALNY in the last 4 months.



There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, all agrees with Geoff's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $50 on, Thursday, August 10th, 2017